Risk factors for multiple pregnancies in intrauterine insemination cycles with ovarian stimulation: a predictive approach
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20243775Keywords:
TMSC, IUI, Infertility, Gonadotropin, FolliclesAbstract
Background: The aim of this study was to predict the risk of multiple pregnancies during ovarian stimulation (OS) followed by intrauterine insemination (IUI) as a treatment for infertility and to identify risk factors associated with multiple pregnancies in IUI cycles.
Methods: This prospective observational study was conducted on 358 couples who underwent OS with IUI between January 2022 and July 2023. Data on maternal and paternal age, type of infertility, gonadotropin dosing, follicular size, and total motile sperm concentration (TMSC) were collected. The primary outcome was clinical pregnancy, defined as the presence of a gestational sac on transvaginal ultrasound (TVS). Descriptive and regression analyses were performed to examine the relationship between these variables and the incidence of multiple pregnancies.
Results: A total of 358 IUI cycles resulted in 57 clinical pregnancies, yielding a pregnancy rate of 15.9%. Among these, 87.7% were singleton pregnancies, and 12.3% were multiple pregnancies. No significant association was found between maternal age, paternal age, or type of infertility and multiple pregnancy outcomes. However, regression analysis revealed that the presence of follicles between 13-15 mm, in combination with larger follicles (>15 mm), significantly increased the likelihood of multiple pregnancies (p=0.007). Additionally, a significant relationship was found between gonadotropin dosing and multiple pregnancy rate (p<0.05), whereas TMSC did not significantly correlate with multiple pregnancy outcomes (p=0.57).
Conclusions: The risk of multiple pregnancies in IUI cycles is significantly associated with follicle size, particularly the presence of follicles in the 13-15 mm range, and higher gonadotropin dosing. While TMSC did not affect multiple pregnancy rates, careful monitoring of ovarian response, especially follicle size, is crucial for minimizing the risk of multiple pregnancies and optimizing clinical outcomes in controlled OS (COS)-IUI cycles.
Metrics
References
Aurell R, Tur R, Torello MJ, Coroleu B, Barri PN. Clinical strategies to avoid multiple pregnancies in assisted reproduction. Gynecological Endocrinol. 2006;22(9):473-8.
Russell RB, Petrini JR, Damus K, Mattison DR, Schwarz RH. The changing epidemiology of multiple births in the United States. Obstetr Gynecolol. 2003;101(1):129-5.
Van Wely M, Twisk M, Mol BW, Van der Veen F. Is twin pregnancy necessarily an adverse outcome of assisted reproductive technologies? Hum Reproduct. 2006;21(11):2736-38.
Ferraretti AP, Goossens V, De Mouzon J, Bhattacharya S, Castilla JA, Korsak V, et al. Assisted reproductive technology in Europe, 2008: Results generated from European registers by ESHRE. Human Reproduction. 2012;27(9):2571-84.
Meseguer M, Rubio I, Cruz M, Basile N, Marcos J, Requena A. Embryo incubation and selection in a time-lapse monitoring system improves pregnancy outcome compared with a standard incubator: A retrospective cohort study. Fertil Steril. 2012;98(6):1481-9.
Domingues AP, Dinis SR, Belo A, Couto D, Fonseca E, Moura P. Impact of induced pregnancies in the obstetrical outcome of twin pregnancies. Fertil Steril. 2014;101(1):172-7.
Sibai BM, Hauth J, Caritis S, Lindheimer MD, MacPherson C, Klebanoff M, et al. for the National Institute of Child Health Human Development Network of Maternal-Fetal Medicine Units. Hypertensive disorders in twin versus singleton gestations. Am J Obstetr Gynecol. 2000;182(4):938-2.
Martin JA, Hamilton BE, Sutton PD, Ventura SJ, Menacker F, Munson ML. Births: final data for 2002. National Vital Statistics Report. 2003;52(10):1-116.
Centers for Disease Control and Prevention, American Society for Reproductive Medicine, Society for Assisted Reproductive Technology. 2011 Assisted reproductive technology national summary report. Atlanta, GA: US Dept. of Health and Human Services. Available at: www.cdc.gov/art/ART2011/ PDFs/ART_2011_National_ Summary_Report.pdf. Accessed on 5 February 2024.
Schwartz DB, Daoud Y, Zazula P, Goyert G, Bronsteen R, Wright D, et al. Gestational diabetes mellitus: Metabolic and blood glucose parameters in singleton versus twin pregnancies. Am J Obstetr Gynecol. 1999;181(4):912-4.
Luke B, Minogue J. The contribution of gestational age and birth weight to perinatal viability in singletons versus twins. J Maternal Fetal Med. 1994;3:263-4.
Morin S, Melzer-Ross K, McCulloh D, Grifo J, Munne S. A greater number of euploid blastocysts in a given cohort predicts excellent outcomes in single embryo transfer cycles. J Assist Reprod Genetics. 2014;31(6):667-3.
Dahdouh EM, Balayla J, Garcıa-Velasco JA. Impact of blastocyst biopsy and comprehensive chromosome screening technology on preimplantation genetic screening: A systematic review of randomized controlled trials. Reprod Biomed Online. 2014;30(3):281-9.
Gleicher N, Oleske DM, Tur-Kaspa I, Vidali A, Karande V. Reducing the risk of high-order multiple pregnancy after ovarian stimulation with gonadotropins. N Engl J Med. 2000;343(1):2-7.
Tur R, Barri PN, Coroleu B, Buxaderas R, Martínez F, Balasch J. Risk factors for high-order multiple implantation after ovarian stimulation with gonadotrophins: evidence from a large series of 1878 consecutive pregnancies in a single centre. Hum Reprod. 2001;16(10):2124-9.